Holen Sie sich die Stockscreener-App
0.5601
1.34%
0.0074
Schlusskurs vom Vortag:
$0.5527
Offen:
$0.549
24-Stunden-Volumen:
501.44K
Relative Volume:
0.02
Marktkapitalisierung:
$22.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+7.59%
1M Leistung:
-14.03%
6M Leistung:
-64.99%
1J Leistung:
-88.95%
1-Tages-Spanne:
$0.5451
$0.5832
1-Wochen-Bereich:
$0.5135
$0.5832
52-Wochen-Spanne:
$0.461
$5.1589
Scienture Holdings Inc Stock (SCNX) Company Profile
Firmenname
Scienture Holdings Inc
Sektor
Branche
Telefon
(800) 261 0281
Adresse
20 AUSTIN BLVD., COMMACK
Vergleichen Sie SCNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.5601 | 22.46M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.66 | 233.46M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
3.32 | 70.95M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
2.80 | 50.83M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
WGRX
Wellgistics Health Inc
|
0.3929 | 41.22M | 28.99M | -39.20M | -3.34M | 0.00 |
|
POM
Pomdoctor Ltd Adr
|
0.32 | 37.11M | 0 | 0 | 0 | 0.00 |
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
How buybacks impact Scienture Holdings Inc. stock valuePortfolio Update Summary & Weekly Sector Rotation Insights - ulpravda.ru
Activity Recap: How buybacks impact Scienture Holdings Inc. stock value2025 Earnings Impact & Daily Chart Pattern Signals - ulpravda.ru
Will Scienture Holdings Inc. stock beat EPS estimatesJobs Report & Weekly Watchlist of Top Performers - ulpravda.ru
Is Scienture Holdings Inc. stock resilient to inflation2025 Major Catalysts & Weekly Momentum Picks - ulpravda.ru
Why Scienture Holdings Inc. stock is trending among retail tradersMean Reversion Trades & Explosive Growth Opportunities - ulpravda.ru
Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
MSN Money - MSN
Will Scienture Holdings Inc stock beat EPS estimates2025 Pullback Review & Weekly Return Optimization Alerts - moha.gov.vn
Scienture Holdings, Inc.Common Stock (Nasdaq:SCNX) Stock Quote - FinancialContent
Scienture Holdings, Inc. (SCNX) - Zacks Investment Research
Scienture Prepares Launch Of REZENOPY, Its Highest-Strength Naloxone Nasal Spray - Nasdaq
SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA - The Globe and Mail
Scienture to launch high-strength naloxone nasal spray in Q2 2026 - Investing.com Nigeria
Is Scienture Holdings Inc stock near bottom after declineJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - moha.gov.vn
Scienture (SCNX) Advances with REZENOPY Nasal Spray Launch - GuruFocus
Scienture to launch high-strength naloxone nasal spray in Q2 2026 By Investing.com - Investing.com South Africa
Scienture provides update on the commercial launch of Rezenopy - marketscreener.com
Scienture Provides Update On The Commercial Launch Of Rezenopy - TradingView — Track All Markets
New 10 mg overdose nasal spray set to reach U.S. market in 2026 - Stock Titan
Is Scienture Holdings Inc. stock a top momentum playPortfolio Performance Summary & Low Drawdown Investment Strategies - Улправда
Will Scienture Holdings Inc. (4E4) stock announce a stock split2025 Retail Activity & Precise Swing Trade Alerts - Улправда
How Scienture Holdings Inc. stock trades during market volatility2025 Technical Overview & Precise Swing Trade Alerts - Улправда
Is Scienture Holdings Inc. (4E4) stock included in top ETFs2025 Winners & Losers & Free High Return Stock Watch Alerts - DonanımHaber
How Scienture Holdings Inc. stock reacts to inflationary pressuresWeekly Trade Review & Risk Controlled Swing Alerts - DonanımHaber
Is Scienture Holdings Inc. stock a good choice for value investorsWeekly Trade Report & Free Weekly Watchlist of Top Performers - DonanımHaber
Is Scienture Holdings Inc. stock positioned for digital transformationTrade Exit Report & Weekly Top Performers Watchlists - DonanımHaber
What analyst consensus implies for Scienture Holdings Inc. (4E4) stockShort Setup & Reliable Breakout Stock Forecasts - DonanımHaber
Movement Recap: Is Scienture Holdings Inc 4E4 stock included in top ETFsJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn
Is Scienture Holdings Inc 4E4 stock included in top ETFsJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn
Scienture, BlinkRx announce strategic collaboration to expand access to Arbli - Yahoo Finance
Why Is Scienture Stock Gaining Today? - Benzinga
Scienture and BlinkRx partner to expand access to liquid losartan By Investing.com - Investing.com Australia
SCNX FinancialsIncome Statement - Quiver Quantitative
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times
Scienture and BlinkRx partner to expand access to liquid losartan - Investing.com India
Scienture (NASDAQ: SCNX) taps BlinkRx to launch Arbli, first ready-to-use losartan oral suspension in Q1 2026 - Stock Titan
Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)
Es liegen keine Finanzdaten für Scienture Holdings Inc (SCNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.63%
2.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):